- Home
- Publications
- Publication Search
- Publication Details
Title
The evolving genomic landscape of urothelial carcinoma
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume 14, Issue 4, Pages 215-229
Publisher
Springer Nature
Online
2017-02-07
DOI
10.1038/nrurol.2017.11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- Tumor heterogeneity offibroblast growth factor receptor 3(FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
- (2016) D. Pouessel et al. ANNALS OF ONCOLOGY
- Spectrum of genomic alterations inFGFR3: current appraisal of the potential role ofFGFR3in advanced urothelial carcinoma
- (2016) Nan Sethakorn et al. BJU INTERNATIONAL
- Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
- (2016) Jakob Hedegaard et al. CANCER CELL
- Understanding mutagenesis through delineation of mutational signatures in human cancer
- (2016) Mia Petljak et al. CARCINOGENESIS
- Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma
- (2016) Aditya Bagrodia et al. JOURNAL OF UROLOGY
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer
- (2016) Hikmat A Al-Ahmadie et al. NATURE GENETICS
- Combine and conquer: challenges for targeted therapy combinations in early phase trials
- (2016) Juanita S. Lopez et al. Nature Reviews Clinical Oncology
- Improving Systemic Chemotherapy for Bladder Cancer
- (2016) Tracy L. Rose et al. Current Oncology Reports
- Genetic and environmental influences interact with age and sex in shaping the human methylome
- (2016) Jenny van Dongen et al. Nature Communications
- Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
- (2016) Vivek Narayan et al. Cancer Research and Treatment
- Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma
- (2016) Stephanie A. Mullane et al. Scientific Reports
- Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations
- (2015) Jeffrey S. Ross et al. CANCER
- HER2 expression status in diverse cancers: review of results from 37,992 patients
- (2015) Min Yan et al. CANCER AND METASTASIS REVIEWS
- Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas
- (2015) F. He et al. CANCER RESEARCH
- Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise
- (2015) J. Kim et al. CLINICAL CANCER RESEARCH
- Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma
- (2015) Metin Kurtoglu et al. Clinical Genitourinary Cancer
- Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification
- (2015) Norma Palma et al. EUROPEAN UROLOGY
- Genomic Characterization of Upper Tract Urothelial Carcinoma
- (2015) John P. Sfakianos et al. EUROPEAN UROLOGY
- Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients
- (2015) Paolo Gontero et al. EUROPEAN UROLOGY
- Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
- (2015) Elizabeth R. Plimack et al. EUROPEAN UROLOGY
- Loss of STAG2 causes aneuploidy in normal human bladder cells
- (2015) X. Li et al. GENETICS AND MOLECULAR RESEARCH
- Dynamics of smoking-induced genome-wide methylation changes with time since smoking cessation
- (2015) Florence Guida et al. HUMAN MOLECULAR GENETICS
- Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061
- (2015) Linda Cerbone et al. ONCOLOGY
- Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot
- (2015) Renate Pichler et al. WORLD JOURNAL OF UROLOGY
- APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity
- (2015) C. Swanton et al. Cancer Discovery
- The inverse relationship between bladder and liver in 4-aminobiphenyl-induced DNA damage
- (2015) Arup Bhattacharya et al. Oncotarget
- Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma
- (2015) Mattias Aine et al. Genome Medicine
- HER2 as a target in invasive urothelial carcinoma
- (2015) Joaquim Bellmunt et al. Cancer Medicine
- The effect of smoking on DNA methylation of peripheral blood mononuclear cells from African American women
- (2014) Meeshanthini V Dogan et al. BMC GENOMICS
- Impact ofERBB2mutations on in vitro sensitivity of bladder cancer to lapatinib
- (2014) Michela de Martino et al. CANCER BIOLOGY & THERAPY
- Genome-wide interaction study of smoking and bladder cancer risk
- (2014) J. D. Figueroa et al. CARCINOGENESIS
- Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
- (2014) Katherine A. Hoadley et al. CELL
- Whole-Exome Sequencing of Muscle-Invasive Bladder Cancer Identifies Recurrent Mutations of UNC5C and Prognostic Importance of DNA Repair Gene Mutations on Survival
- (2014) K. L. Yap et al. CLINICAL CANCER RESEARCH
- Targeted therapies in urothelial carcinoma
- (2014) Monalisa Ghosh et al. CURRENT OPINION IN ONCOLOGY
- Clinical significance of fibroblast growth factor receptor-3 mutations in bladder cancer: a systematic review and meta-analysis
- (2014) X. Liu et al. GENETICS AND MOLECULAR RESEARCH
- Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
- (2014) S. D. Brown et al. GENOME RESEARCH
- Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer
- (2014) Meilin Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Human papillomavirus infection and pathogenesis in urothelial cells: A mini-review
- (2014) Kazuyoshi Shigehara et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism
- (2014) Jaime Acquaviva et al. MOLECULAR CANCER RESEARCH
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder
- (2014) Lily C. Wang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma
- (2014) E. M. Van Allen et al. Cancer Discovery
- Synthetic Lethality in ATM-Deficient RAD50-Mutant Tumors Underlies Outlier Response to Cancer Therapy
- (2014) H. Al-Ahmadie et al. Cancer Discovery
- Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib
- (2014) N. Wagle et al. Cancer Discovery
- Combination of molecular alterations and smoking intensity predicts bladder cancer outcome
- (2013) Anirban P. Mitra et al. CANCER
- Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis
- (2013) Firas Abdollah et al. Cancer Epidemiology
- The CpG Island Methylator Phenotype: What's in a Name?
- (2013) L. A. E. Hughes et al. CANCER RESEARCH
- Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma
- (2013) Mariana Brait et al. CELL CYCLE
- Alterations of DNA methylome in human bladder cancer
- (2013) Ahmad Besaratinia et al. Epigenetics
- Effect of Smoking on Outcomes of Urothelial Carcinoma: A Systematic Review of the Literature
- (2013) Joseph J. Crivelli et al. EUROPEAN UROLOGY
- Epigenomic association analysis identifies smoking-related DNA methylation sites in African Americans
- (2013) Yan V. Sun et al. HUMAN GENETICS
- Age-associated epigenetic drift: implications, and a case of epigenetic thrift?
- (2013) A. E. Teschendorff et al. HUMAN MOLECULAR GENETICS
- Smoke-related DNA methylation changes in the etiology of human disease
- (2013) Welisane Besingi et al. HUMAN MOLECULAR GENETICS
- FGF Receptors: Cancer Biology and Therapeutics
- (2013) Masaru Katoh et al. MEDICINAL RESEARCH REVIEWS
- APOBEC3B is an enzymatic source of mutation in breast cancer
- (2013) Michael B. Burns et al. NATURE
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation
- (2013) Guangwu Guo et al. NATURE GENETICS
- Frequent truncating mutations of STAG2 in bladder cancer
- (2013) David A Solomon et al. NATURE GENETICS
- Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
- (2013) Cristina Balbás-Martínez et al. NATURE GENETICS
- Pan-cancer patterns of somatic copy number alteration
- (2013) Travis I Zack et al. NATURE GENETICS
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Identification of Targetable FGFR Gene Fusions in Diverse Cancers
- (2013) Yi-Mi Wu et al. Cancer Discovery
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Bladder cancer, a review of the environmental risk factors
- (2012) Silvia Letašiová et al. Environmental Health
- Oncogenic FGFR3 gene fusions in bladder cancer
- (2012) Sarah V. Williams et al. HUMAN MOLECULAR GENETICS
- Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression
- (2012) Paul Chih-Hsueh Chen et al. JOURNAL OF CLINICAL PATHOLOGY
- Effects of Cigarette Smoke Condensate on Primary Urothelial Cells in Vitro
- (2012) Sabine Plöttner et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES
- Clustered Mutations in Yeast and in Human Cancers Can Arise from Damaged Long Single-Strand DNA Regions
- (2012) Steven A. Roberts et al. MOLECULAR CELL
- Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
- (2012) D. Singh et al. SCIENCE
- Genome Sequencing Identifies a Basis for Everolimus Sensitivity
- (2012) G. Iyer et al. SCIENCE
- Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?
- (2011) Robert Segal et al. BJU INTERNATIONAL
- Association Between Smoking and Risk of Bladder Cancer Among Men and Women
- (2011) Neal D. Freedman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
- (2011) Yaoting Gui et al. NATURE GENETICS
- DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines
- (2011) Jordana T Bell et al. GENOME BIOLOGY
- Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors
- (2010) Matthew D. Galsky et al. INVESTIGATIONAL NEW DRUGS
- Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis
- (2010) Eric Letouzé et al. GENOME BIOLOGY
- A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma
- (2009) Christian Wülfing et al. CANCER
- Phase I and Pharmacokinetic Study of Lapatinib and Docetaxel in Patients With Advanced Cancer
- (2008) Patricia M. LoRusso et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now